| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/27/2006 | WO2006078256A2 Polypeptides having xylanase activity and polynucleotides encoding same |
| 07/27/2006 | WO2006078224A1 Enzymatic electrochemical detection assay using protective monolayer and device therefor |
| 07/27/2006 | WO2006078042A1 Method for detection of small rna and reagent for detection of small rna |
| 07/27/2006 | WO2006078034A1 Cells capable of differentiating into cardiac muscle cells |
| 07/27/2006 | WO2006077981A1 High-throughput functionality evaluation method, program and apparatus |
| 07/27/2006 | WO2006077954A1 Remedy for neurological disease |
| 07/27/2006 | WO2006077874A1 Polymorphism of gene encoding drug metabolizing enzyme in monkey and the use thereof |
| 07/27/2006 | WO2006077873A1 Novel drug metabolizing enzyme in monkey and nucleic acid encoding the same |
| 07/27/2006 | WO2006077631A1 Method of systematic analysis of relevant gene in relevant genome region (including relevant gene/relevant haplotype) |
| 07/27/2006 | WO2006077610A1 Nucleotidic sequences sets construction method for the preparation of oligonucleotides to be used for analysing organisms or organism groups whose nucleotidic sequences are not completely known |
| 07/27/2006 | WO2006077586A2 Polydiacetylene-containing solid colorimetric and/or fluorescent detector, method for its preparation and uses thereof |
| 07/27/2006 | WO2006077585A2 Apparatus and method for control of tunneling in a small-scale electronic structure |
| 07/27/2006 | WO2006077411A1 Polypeptide mutagenesis method |
| 07/27/2006 | WO2006077322A1 Non-invasive, prenatal, in-vitro method for detecting the normal healthy condition, the condition of a healthy carrier or the condition of a carrier inflicted with cystic fibrosis |
| 07/27/2006 | WO2006077248A1 Nucleic acid variants in the ficolin genes associated with altered innate immunity |
| 07/27/2006 | WO2006077241A2 Kringle domains in a calcium sensor fusion protein |
| 07/27/2006 | WO2006077126A2 Cx3cr1 as a marker which correlates with both disease and disease activity in multiple sclerosis patients |
| 07/27/2006 | WO2006077102A2 Method for the detection of hpv and probes, primers and kits |
| 07/27/2006 | WO2006077099A1 Identification of hpv16 lineage group |
| 07/27/2006 | WO2006076912A2 Method for the hybridisation of nucleic acids |
| 07/27/2006 | WO2006076793A1 Dna sequence recognition |
| 07/27/2006 | WO2006065597A3 Id-tag complexes, arrays, and methods of use thereof |
| 07/27/2006 | WO2006045874A3 Use of the slug gene or the replication, transcription or expression products thereof in the identification, diagnosis, prevention or treatment of the spread of cancer and/or the development of metastasis |
| 07/27/2006 | WO2006045799A3 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| 07/27/2006 | WO2006044643A3 Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 07/27/2006 | WO2006043095A8 Monitoring enzyme-substrate reactions |
| 07/27/2006 | WO2006039622A3 Feeding buffers, systems, and methods for in vitro synthesis of biomolecules |
| 07/27/2006 | WO2006034431A3 Genetic selection of small molecule modulators of protein-protein interactions |
| 07/27/2006 | WO2006034319A3 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 07/27/2006 | WO2006033933A3 Antisense antiviral compound and method for treating ssrna viral infection |
| 07/27/2006 | WO2006031363A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/27/2006 | WO2006029052A3 Methods for assessing atherosclerosis |
| 07/27/2006 | WO2006026478A3 Compositions and methods for improving heart function |
| 07/27/2006 | WO2006024751A3 Method for the simultaneous detection and identification of different animal or plant species in a sample of organic material |
| 07/27/2006 | WO2006014798A3 Methods and compositions for using sax2 |
| 07/27/2006 | WO2006008128A3 Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders |
| 07/27/2006 | WO2005124343A3 Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions |
| 07/27/2006 | WO2005118872A3 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases |
| 07/27/2006 | WO2005116243A3 Improvements to diagnostic assays that use mycobacteriophages |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005113800A3 Method and device for monitoring aspirin response |
| 07/27/2006 | WO2005110596A3 Methods of quantifying targets in multiple samples |
| 07/27/2006 | WO2005110459A3 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 07/27/2006 | WO2005108599A3 Compositions and methods for treatment of protein misfolding diseases |
| 07/27/2006 | WO2005100600A3 Ionic based sensing for identifying genomic sequence variations and detecting mismatch base pairs, such as single nucleotide polymorphisms |
| 07/27/2006 | WO2005070027A8 A novel nucleotide mixture for improved nucleic acid amplification performance |
| 07/27/2006 | WO2005070020A3 Gefitinib sensitivity-related gene expression and products and methods related thereto |
| 07/27/2006 | WO2005062979A3 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/27/2006 | WO2005060725A8 Nucleic acid amplification methods |
| 07/27/2006 | WO2005060675A3 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/27/2006 | WO2005029041A3 High density sequence detection methods and apparatus |
| 07/27/2006 | WO2005020902A3 Compositions and methods for treating and diagnosing irritable bowel syndrome |
| 07/27/2006 | WO2004113555A3 Identifying, monitoring, and sorting genetically modified plant portions |
| 07/27/2006 | WO2004091479A3 Gene amplification and overexpression in cancer |
| 07/27/2006 | WO2004074456A3 Methods for selecting medications |
| 07/27/2006 | WO2004065553A3 Method for comprehensive identification of cell lineage specific genes |
| 07/27/2006 | WO2004055197A3 Thermodynamic equilibrium extension of primers |
| 07/27/2006 | WO2004053081A3 Compositions, splice variants and methods relating to prostate specific genes and proteins |
| 07/27/2006 | WO2004048432A3 Preparation of polyphosphazene microspheres |
| 07/27/2006 | WO2004033397A3 Activity-based probes, and methods of their preparation and use |
| 07/27/2006 | WO2004024890A3 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 07/27/2006 | WO2004023270A3 Crystal structure of angiotensin-converting enzyme-related carboxypeptidase |
| 07/27/2006 | WO2004005883A3 Secreted and cytoplasmic tumor endothelial markers |
| 07/27/2006 | WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof |
| 07/27/2006 | US20060168695 Transgenic bacteria, plant, cells, cell cultures, parts, tissues, organs or propagation materials; targeted transgenic expression of nucleic acid sequences |
| 07/27/2006 | US20060168694 Male sterility restoration as a selectable marker in plant transformation |
| 07/27/2006 | US20060168693 Transforming plant with a DNA construct comprising a promoter that functions in plants, operably linked to a DNA molecule that encodes a protein, wherein promoter is heterologous to the DNA molecule; transgenic plants |
| 07/27/2006 | US20060168691 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 07/27/2006 | US20060168676 Novel inducible genes from alfalfa and methods of use thereof |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168670 identification of new gene families that are differentially expressed in cancerous human tissues compared to normal human tissues; useful as diagnostic agents or markers to detect cancer or to differentiate carcinoma from normal tissue in a sample; nucleotide sequence |
| 07/27/2006 | US20060168668 Phosphodiesterase 2a and methods of use |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060167231 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2006 | US20060167227 Truncated tau proteins |
| 07/27/2006 | US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same |
| 07/27/2006 | US20060166922 Polynucleotides targeted against the extended 5'-UTR region of argininosuccinate synthase and uses thereof |
| 07/27/2006 | US20060166918 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample |
| 07/27/2006 | US20060166914 Method of nucleic acid infusion |
| 07/27/2006 | US20060166912 Use of cytochrome p450 enzyme cyp2w1 as a drug target for cancer theraphy |
| 07/27/2006 | US20060166911 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 07/27/2006 | US20060166910 Rna-interference by single-stranded rna molecules |
| 07/27/2006 | US20060166909 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 07/27/2006 | US20060166867 Argininamido-neomycin B conjugates; aminoglycoside antibiotics; for prevention and treatment of HIV infection |
| 07/27/2006 | US20060166352 Device and method for analyte detection |
| 07/27/2006 | US20060166333 Testing for human papillomavirus or host genetic markers by applying an absorbent and porous material onto introitus of a female patient to collect vaginal discharge, either briefly as an imprint or swab; air drying; disposable underwear; nucleic acid amplification; diagnosis |
| 07/27/2006 | US20060166331 Pharmaceutical grade manufacture of quality plasmid DNA from cell lysates using flotation to separate and eliminate undesired insoluble cellular debris including chromosomal DNA from the lysates |
| 07/27/2006 | US20060166324 Screening tools for discovery of novel anabolic agents |
| 07/27/2006 | US20060166305 Animal cell confluence detection method and apparatus |
| 07/27/2006 | US20060166304 Polynucleotides encoding insect 3-ketosphinganine reductase and uses thereof |
| 07/27/2006 | US20060166303 Use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs |
| 07/27/2006 | US20060166302 Handheld raman blood analyzer |
| 07/27/2006 | US20060166301 Stable chromogenic test reagent and its use in coagulation-diagnostic tests |
| 07/27/2006 | US20060166300 Method of measuring homocysteine |
| 07/27/2006 | US20060166299 based on the finding that fifteen proteins surprisingly were either down- or up-regulated in type 2-diabetes; Eleven of these proteins (markers for type 2 diabetes) were positively identified by mass spectrometry |
| 07/27/2006 | US20060166289 Method for analyzing tumor agressivity comprising measurement of polymerized actin |
| 07/27/2006 | US20060166288 Assay for the screening of compounds acting through erbb-2 |
| 07/27/2006 | US20060166283 Means for detecting neurodegenerative processes and applications of same |
| 07/27/2006 | US20060166281 Tissue targeted therapy; identifying antitumor agents specific to transphosphorylase domain of c-kit; interleulin-3 cell targeting |
| 07/27/2006 | US20060166275 Amyloid beta protein (globular assembly and uses thereof) |